Literature DB >> 15186192

Quantifying actinic keratosis: assessing the evidence.

Ernst Epstein1.   

Abstract

Actinic keratoses are pre-malignant lesions, and it is standard practice to destroy them. Optimal management of actinic keratoses requires data on the efficacy of the numerous techniques employed in their treatment. Evaluating treatment efficacy requires before and after treatment quantification of actinic keratoses. Studies on the therapy and natural history of actinic keratoses have quantified these lesions by counting them. Counting actinic keratoses is unreliable because this technique lacks interobserver reproducibility. Consequently, studies based on counting actinic keratoses are fatally flawed and their conclusions of doubtful accuracy. Counting actinic keratoses should be abandoned as a technique for evaluating the therapy of actinic keratoses and the issue of spontaneous regression of actinic keratoses. A technique for reliably quantifying actinic keratoses is sorely needed.

Entities:  

Mesh:

Year:  2004        PMID: 15186192     DOI: 10.2165/00128071-200405030-00001

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  4 in total

Review 1.  Retinoids for prevention and treatment of actinic keratosis.

Authors:  Mayra Ianhez; Luiz Fernando Fróes Fleury; Hélio Amante Miot; Edileia Bagatin
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

2.  Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization.

Authors:  Christopher Baker; Amelia James; Madeleine Supranowicz; Lynda Spelman; Stephen Shumack; Judith Cole; Warren Weightman; Robert Sinclair; Peter Foley
Journal:  Clin Exp Dermatol       Date:  2022-03-22       Impact factor: 4.481

3.  Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).

Authors:  Zeeshaan-Ul Hasan; Ikhlaaq Ahmed; Rubeta N Matin; Victoria Homer; John T Lear; Ferina Ismail; Tristan Whitmarsh; Adele C Green; Jason Thomson; Alan Milligan; Sarah Hogan; Vanessa Van-de-Velde; Liza Mitchell-Worsford; Jonathan Kentley; Claire Gaunt; Yolande Jefferson-Hulme; Sarah J Bowden; Piers Gaunt; Keith Wheatley; Charlotte M Proby; Catherine A Harwood
Journal:  Br J Dermatol       Date:  2022-06-14       Impact factor: 11.113

4.  Thickness of Actinic Keratosis Does Not Predict Dysplasia Severity or P53 Expression.

Authors:  Ida M Heerfordt; Christoffer V Nissen; Thomas Poulsen; Peter A Philipsen; Hans Christian Wulf
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.